Cited by 21Attention Deficit Hyperactivity DisorderVasculitis and related conditionsSchizophrenia research and treatment

Peripheral Vasculopathy Associated with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder

Yu, Zheya Jenny, Parker-Kotler, Caroline, Tran, Kathleen, Weller, Ronald A., Weller, Elizabeth B.·2010·Current Psychiatry Reports

Abstract

Psychostimulants (methylphenidate and amphetamine salt) are the pharmacologic treatment of choice for children with attention-deficit/hyperactivity disorder. However, psychostimulants have been linked to a variety of vascular problems, including peripheral vasculopathy. This article describes four boys with attention-deficit/hyperactivity disorder who developed vasculopathy during treatment with psychostimulants.

Integrity signals

Registry

Crossref · 10.1007/s11920-010-0093-y

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Serious cardiovascular side-effects have been identified with stimulant use.

    “Although rare, serious cardiovascular side-effects have been identified with stimulant use [54]”

    From Advances in understanding and treating ADHD (2011) · cites this paper as [54]

The citation lists haven’t been fetched yet

References 12 · Cited by 21

Authors
Yu, Z. J., Parker-Kotler, C., Tran, K., Weller, R. A., & Weller, E. B.
Affiliations
  • Pennsylvania Hospital (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • University of Pennsylvania (US)
  • Children's Hospital of Philadelphia (US)
Corresponding author
Yu, Zheya Jenny
Venue
Current Psychiatry Reports
Published
2010-03-20
Volume
12
Issue
2
Pages
111-115
ISSN
  • 1523-3812 (ISSN-L)
  • 1535-1645
OpenAlex
W2018209581
Cited by
21
References
12
Citations by year
2026: 1 · 2025: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 2 · 2016: 2 · 2015: 3 · 2014: 1 · 2012: 1
FWCI
0.65
Type
journal article
Language
en
Open access
closed
Locations
  • Current Psychiatry Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vasculitis and related conditions
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
peripheral vascular disease, psychostimulants, attention deficit hyperactivity disorder, methylphenidate, amphetamine, adverse drug reactions, children
MeSH terms
Adolescent, Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Male, Methylphenidate, Severity of Illness Index, Peripheral Vascular Diseases, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review